Amelioration of Glucolipotoxicity-Induced Endoplasmic Reticulum Stress by a “Chemical Chaperone” in Human THP-1 Monocytes by Lenin, Raji et al.
Hindawi Publishing Corporation
Experimental Diabetes Research
Volume 2012, Article ID 356487, 10 pages
doi:10.1155/2012/356487
Research Article
Amelioration of Glucolipotoxicity-Induced
EndoplasmicReticulumStress by a “Chemical Chaperone” in
HumanTHP-1 Monocytes
Raji Lenin,1 Mariawilliam Sneha Maria,1 Madhur Agrawal,1 Jayashree Balasubramanyam,2
ViswanathanMohan,1 andMuthuswamy Balasubramanyam1
1Department of Cell and Molecular Biology, Madras Diabetes Research Foundation and Dr. Mohans’ Diabetes Specialities Centre,
Chennai 600086, India
2Centre for Biotechnology, Anna University, Chennai 600025, India
Correspondence should be addressed to Muthuswamy Balasubramanyam, balusignal@gmail.com
Received 17 December 2011; Accepted 13 February 2012
Academic Editor: Rangasamy Sampathkumar
Copyright © 2012 Raji Lenin et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Chronic ER stress is emerging as a trigger that imbalances a number of systemic and arterial-wall factors and promote atheroscle-
rosis.Macrophageapoptosiswithinadvancedatheroscleroticlesionsisalsoknowntoincreasetheriskofatherothromboticdisease.
We hypothesize that glucolipotoxicity might mediate monocyte activation and apoptosis through ER stress. Therefore, the aims of
this study are (a) to investigate whether glucolipotoxicity could impose ER stress and apoptosis in THP-1 human monocytes and
(b) to investigate whether 4-Phenyl butyric acid (PBA), a chemical chaperone could resist the glucolipotoxicity-induced ER stress
and apoptosis. Cells subjected to either glucolipotoxicity or tunicamycin exhibited increased ROS generation, gene and protein
(PERK, GRP-78, IRE1α, and CHOP) expression of ER stress markers. In addition, these cells showed increased TRPC-6 channel
expression and apoptosis as revealed by DNA damage and increased caspase-3 activity. While glucolipotoxicity/tunicamycin
increased oxidative stress, ER stress, mRNA expression of TRPC-6, and programmed the THP-1 monocytes towards apoptosis,
all these molecular perturbations were resisted by PBA. Since ER stress is one of the underlying causes of monocyte dysfunction
in diabetes and atherosclerosis, our study emphasize that chemical chaperones such as PBA could alleviate ER stress and have
potential to become novel therapeutics.
1.Introduction
Cardiovascular complications due to atherosclerotic disease
are a frequent cause of morbidity and mortality in patients
with diabetes [1]. A role for immune cells such as monocytes
and lymphocytes has been implicated in the pathogenesis of
diabetes and its various complications including atheroscle-
rosis. Clinical and experimental evidence indicates that
inﬂammatory processes in the vascular wall are the decisive
factor that accounts for the rate of lesion formation and
clinical development in patients suﬀering from atheroscle-
rosis [2]. Monocytes and macrophages, in an attempt to
engulf lipid laden cells along the blood vessel, will get
exposed to hyperglycemia and hyperlipidemia, a combined
pathophysiological situation referred to as “glucolipotox-
icity.” The exact mechanisms by which glucolipotoxicity
triggers monocyte activation and atherosclerotic processes
are not clearly understood. However, evidence indicates that
ER stress plays an important role in these mechanisms.
ER stress is known to activate a series of signals that
comprise the unfolded protein response (UPR). The UPR
includes at least three signaling pathways initiated by the
kinases IRE1 and PERK and the transcription factor ATF6
[3] signals that coordinate the cellular response to unfolded
proteins, which includes (a) downregulation of protein
translation, (b) enhanced expression of ER chaperone pro-
teins that promote protein refolding, and (c) activation of
proteases involved in the degradation of misfolded proteins.2 Experimental Diabetes Research
Conversely,prolongedorsevereERstresscanleadtotheacti-
vation of apoptotic cell death. Recent studies have suggested
that chronic ER stress originating from glucolipotoxicity is
one of the major culprits that can very well explain the
underlying causes of both insulin resistance and β-cell dys-
function[4–7].ERstresshasbeenlinkedtoinsulinresistance
in diabetes and also expansion of ER was detected in β-cells
from type 2 diabetic patients [8, 9]. Furthermore, increased
expression of ER stress markers has been demonstrated in
db/db mouse islets and β-cells of type 2 diabetes patients
[9, 10]. Recent studies also imply that β-cell dysfunction by
glucolipotoxicity-induced ER stress is mediated by increased
oxidative stress and apoptosis [11]. While the recruitment
of monocytes and their retention within atherosclerotic
lesions contribute to plaque development [12], macrophage
apoptosis within advanced atherosclerotic lesions is also
known to increase the risk of atherothrombotic disease
[13]. Although glucolipotoxicity is known to trigger ER
stress, its eﬀect on various arms of the ER stress machinery
in monocytes has not been clearly deﬁned. Therefore, we
investigated the eﬀect of glucolipotoxicity on monocytes
with reference to ROS generation, transcriptional alterations
of various ER stress markers, and apoptotic indicators. We
also investigated the eﬀect of 4-phenyl butyric acid (PBA,
a chemical chaperone) whether it resists glucolipotoxicity-
induced ER stress and apoptosis.
2.MaterialsandMethods
2.1.CellCultureandTreatment. ThehumanmonocyteTHP-
1 cells were obtained from the National Centre for Cell
Science (NCCS, Pune, India). THP-1 cells were maintained
in endotoxin-free RPMI-1640 containing 5.5mM glucose,
10% (v/v) heat-inactivated fetal bovine serum, 100U/mL
penicillin, 100μg/mL streptomycin, 2.5μg/L amphotericin
B, 2mM L-glutamine, 1mM sodium pyruvate and 10mM
HEPES, pH 7.0–7.4, under a humidiﬁed condition of 5%
CO2 at 37◦C. For all the experiments, cells were subjected
toeither5.5mM glucose(basal)orglucolipotoxicity (25mM
glucose plus 0.5mM palmitic acid) or tunicamycin (4μM)
treatment for 24h in the presence and absence of 4-
PBA (1mM), in serum-free medium. All experiments were
independently performed at least thrice.
2.2. Intracellular Reactive Oxygen Species (ROS) Measure-
ment. Intracellular ROS generation was measured in THP-
1 monocytes as described earlier [14] with minor modi-
ﬁcations as to the confocal application. Brieﬂy, 1 × 103
cells were seeded in confocal chambered slides (LabTek II)
precoated with 0.01% poly-L-lysine. After the treatment
conditions, 2 ,7 -dichlorodihydroﬂuorescein diacetate (H2-
DCFDA, 10μM) dye was added to each well and incubated
for 30min at 37◦C. Cells were then washed twice with PBS.
To capture the change in ﬂuorescence, cells were excited at a
wavelengthof485nmandtheﬂuorescenceemissionwasread
at 530nm using Carl Zeiss-LSM 700 confocal microscope
with an objective of 20x. Change in mean ﬂuorescence
intensity was represented as arbitrary units (AU).
2.3. Real-Time PCR
2.3.1. RNA Isolation. Total RNA from cells was isolated
as described previously [15]. The RNA quality and con-
centration of total RNA were measured using nanodrop.
1μg of RNA was converted to cDNA using 100 units
reverse transcriptase enzyme, 40μM Oligo-dT18 primer
(New England Biolabs), 10xRT buﬀer, 20U RNase inhibitor
(Amersham Biosciences), and 2.5mM each of dNTPS and
incubated at 42◦Cf o r1h .
2.3.2. Quantitative Real-Time PCR. Quantitative real-time
PCR was performed for speciﬁc genes using SYBR green
master mix (Finnzymes). PCR ampliﬁcation was carried out
using ABI-7000 (Applied Biosystems) with cycle conditions
(initial cycle: 50◦C for 2min, Initial denaturation 95◦C
for 15sec, 40 cycles of denaturation 95◦C for 15sec, and
annealing/extension of 60◦C for 1min). The expression level
of RNA was determined using 2−DDCt a n dn o r m a l i z e du s i n g
β-actin. The primer sequences of speciﬁc genes are listed in
Table 1.
2.4. Protein Expression. After speciﬁc treatments, cells were
lysed using RIPA buﬀer (50mM Tris-HCl (pH 8.0), 150mM
NaCl, 0.1% SDS, 0.2% sodium azide, 1% Triton X-100,
0.25% sodium deoxycholate, and 1x protease inhibitor). In
brief, cells were sonicated and incubated for 1hr in ice and
centrifugedat16,000gfor5minutesat4◦C.Thesupernatant
collected was quantiﬁed for protein by Bradford method.
15μg protein was resolved on a 10% SDS-PAGE and trans-
ferred to polyvinylidine ﬂuoride (PVDF) membrane. After 1
hour blocking in 5% bovine serum albumin (BSA) and incu-
bation with the appropriate primary antibodies and HRP-
conjugated secondary antibodies, detection was performed
using enhanced chemiluminescence kit (GE Healthcare). β-
actin was used as internal control. Mean densitometry data
from independent experiments were normalized to control
using Image-J software and represented as the ratio of test
protein and β-actin.
2.5. DNA Damage—Comet Assay. DNA damage was eval-
uated with the Comet assay as described previously [16].
Brieﬂy, the treated cells were mixed with 200μLo f0 . 5 %
low-melting point agarose and layered over clear microscope
slides precoated with 1% normal melting agarose. Lysis,
electrophoresis, and neutralization were followed by staining
with ethidium bromide. The slides were examined under a
ﬂuorescent microscope. They were scored using an image
analysis system (Comet Imager 1.2.13) attached to a ﬂu-
orescent microscope (Carl-Zeiss, Germany) equipped with
appropriate ﬁlter.
2.6. Caspase 3 Activity Assay. Caspase-3 activity was deter-
mined by colorimetric assay using the caspase-speciﬁc
peptide containing amino acid sequence Asp-Glu-Val-Asp
(DEVD) that is conjugated to the color reporter molecule
p-nitroanilide (pNA) (RandD systems). The cleavage of the
peptide by the caspases releases the chromophore pNA,Experimental Diabetes Research 3
Table 1: Primer sequence of speciﬁc genes.
GRP78 Forward CTG CCA TGG TTC TCA CTA AAA TG
Reverse TTA GGC CAG CAA TAG TTC CAG
PERK Forward GAA CCA GAC GAT GAG ACA GAG
Reverse GGA TGA CAC CAA GGA ACC G
IRE1 Forward GCG AAC AGA ATA CAC CAT CAC
Reverse ACC AGC CCA TCA CCA TTG
XBP1 Forward TGG ATT CTG GCG GTA TTG AC
Reverse TCC TTC TGG GTA GAC CTCTG
ATF-6 Forward CCT GTC CTA CAA AGT ACC ATG AG
Reverse CCT TTA ATC TCG CCT CTA ACC C
CHOP/GADDForward GTA CCT ATG TTT CAC CTC CTG G
Reverse TGG AAT CTG GAG AGT GAG GG
TRPC6
Forward TTT GAG GAG GGC AGA ACA CTT
CCT
Reverse TAT GGC CCT GGA ACA GCT CAG AAA
β-actin Forward GTC TTC CCC TCC ATC GT
Reverse CGT CGC CCA CAT AGG AAT
which is quantiﬁed spectrophotometrically at 405nm. Cells
harvested after treatment were lysed and 10μgp r o t e i nw a s
aliquoted from each sample into a 96 well plate. 0.5μLD T T
was added to all the wells followed by addition of 50μL
of 2x reaction buﬀer and 3.5μL of Caspase-3 colorimetric
substrate. The plate was incubated at 37◦Cf o r1h ra n dr e a d
at 405nm using microplate reader. Caspase-3 activity was
expressed as mean ± SEM of optical density.
2.7.StatisticalAnalysis. StatisticalPackageforSocialSciences
(SPSS) Windows, (Version 16.0, Chicago, IL), was used for
statistical analysis. Data were expressed as Mean ± SEM.
Comparisons between groups were performed using stu-
dent’s t-test and a P-value < 0.05 was considered statistically
signiﬁcant.
3. Results
We have applied confocal microscopy to measure the ﬂu-
orescent intensity of DCF which indicates the extent of
intracellular ROS generation in monocytes. While represen-
tative ﬂuorescent images related to ROS generation were
depicted in Figure 1(a), cumulative data on ROS generation
were presented in Figure 1(b). Cells subjected to either
glucolipotoxicity or tunicamycin exhibited increased ROS
generation compared to the untreated cells (Figure 1(b)).
Pretreatment of cells with 4-phenyl butyric acid showed
signiﬁcant reduction in ROS generation (P<0.05). A
complete mRNA expression pattern of ER stress machinery
was determined by real-time PCR and the cumulative data
on mRNA pattern of ER stress markers in relation to their
ratiowiththehousekeepingβ-actinwasdepictedinFigure 2.
Compared to untreated cells, cells treated with glucolipotox-
icity or tunicamycin showed an increased mRNA expression
of PERK, GRP78, IRE1α,X B P 1 ,A T F 6 ,a n dC H O P( F i g u r e s
2(a)–2(f)). It is also interesting to note that the extent
increase in ER stress markers under glucolipotoxicity was
higher than that induced by tunicamycin. PBA treatment
signiﬁcantly reduced all the transcriptional expression of
ER stress markers most likely due to its chaperone activity.
Figure 3(A) depicts the representative protein expression of
ER stress markers along with β-actin. Consistent with the
mRNA results, protein expression of ER stress markers,
namely,PERK,GRP78,IRE1α,andXBP1werealsoincreased
in cells subjected to glucolipotoxicity and tunicamycin treat-
ment (Figure 3(B)). 4-PBA treatment signiﬁcantly reduced
the protein expression of all the ER stress markers.
Since the programming of apoptosis by both the oxida-
tive and ER stress signals depend on the load of intracellular
Ca2+, we investigated the transcriptional level of TRPC-
6, which is an important driving force for increased Ca2+
inﬂux. Cells treated with glucolipotoxicity or tunicamycin
resulted in several folds of increase in TRPC-6 mRNA levels
(Figure 4) and this was signiﬁcantly normalized by PBA.
Comparedtountreatedcells,cellstreatedwithglucolipo-
toxicity or tunicamycin showed increased DNA damage (4.6
and 3 folds, resp.). Interestingly, PBA treatment signiﬁcantly
reducedtheDNAdamageinducedeitherbyglucolipotoxicity
or tunicamycin (Figure 5(a)). Since CHOP (an intermediate
in caspase-dependent apoptosis) mRNA and protein expres-
sion were increased in cells subjected to glucolipotoxicity or
tunicamycin, we estimated the activity of caspase-3 enzyme.
As expected, cells treated with glucolipotoxicity or tuni-
camycin showed signiﬁcantly increased caspase-3 activity
(Figure 5(b)) implying that uncontrolled ER stress might
have programmed the cells towards apoptosis. Increased
caspase-3 activity either due to glucolipotoxicity or tuni-
camycin was signiﬁcantly (P<0.05) reduced by 4-PBA.
4. Discussion
The following are the nutshell ﬁndings of the study. First,
monocytes subjected to glucolipotoxicity showed increased
ROS generation and increased mRNA expression of several
genes of the ER stress machinery. Secondly, these monocytes
exhibited features of chronic ER stress as evidenced by
increased mRNA expression of TRPC-6, DNA damage, and
caspase-3 activity. Thirdly, PBA—a chemical chaperone,
resisted all the glucolipotoxicity-induced cellular and molec-
ular alterations in monocytes emphasizing the beneﬁts of ER
stress alleviation.
Monocyte activation, adhesion to the endothelium,
and transmigration into the subendothelial space are
key events in early pathogenesis of atherosclerosis. The
mechanisms by which glucose and lipid toxicity induces
monocyte-associated atherosclerosis are only partially
known. Mononuclear blood cells from patients with diabetes
show increased generation of reactive oxygen species and
altered redox signaling [16–21]. In our study, monocytes
subjected to glucolipotoxicity exhibited increased generation
of ROS. ROS could activate cell death processes directly
by the oxidation of proteins, lipids, and/or nucleic acids
or could act as initiators or second messengers in the cell4 Experimental Diabetes Research
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Figure 1: (a) Representative confocal microscopy images of Intracellular ROS generation in cells treated under various conditions. (b) Mean
(±SEM)ﬂuorescenceintensitiesofROSunderdiﬀerentexperimentalmaneuvers,namely,control,glucolipotoxicity(GLT),glucolipotoxicity
+ 4-phenyl butyric acid (GLT + PBA), tunicamycin (Tun), tunicamycin + 4-phenyl butyric acid (Tun + PBA), 4-phenyl butyric acid (PBA).
∗P<0.05 compared to control, #P<0.05 compared to GLT, ∗∗P<0.05 compared to tunicamycin.
death process. Accumulating evidence suggests that protein
folding and generation of reactive oxygen species (ROS)
as a byproduct of protein oxidation in the ER are closely
linked events. It has also become apparent that activation
of the UPR on exposure to oxidative stress is an adaptive
mechanism to preserve cell function and survival. However,
persistent oxidative stress and protein misfolding initiate
apoptotic cascades and are now known to play predominant
roles in the pathogenesis of multiple human diseases
including diabetes and atherosclerosis [22–24].
A number of hypotheses have been conceived to explain
advanced lesional macrophage apoptosis and atherosclerosis,
and undoubtedly more than one mechanism is involved.
R e c e n tm e c h a n i s t i cd a t ai nc u l t u r e dc e l l sa n dc o r r e l a t i v e
and genetic causation evidence in vivo support a role for
endoplasmic reticulum (ER) stress in advanced lesional
macrophage apoptosis and its major consequence of plaque
necrosis [13, 25]. Consistent with previous ﬁndings, glucol-
ipotoxicity in our study showed increased transcription of
PERK, GRP78, IRE1α,X B P - 1 ,A T F 6 ,a n dC H O Pi nm o n o -
cytes. This was also corroborated by the increased protein
expression of ER stress markers. The fact that increased
expression of ER stress markers under glucolipotoxicity is
similar to that induced by tunicamycin (a known inducer of
ERstress)emphasizesthatglucolipotoxicityinductsERstress
in monocytes.
Increased TRPC-6 mRNA expression under glucolipo-
toxicity in our study implies a role for increased calcium
levels in monocyte dysfunction and ER stress. Calcium is an
essential intracellular messenger and serves critical cellular
functions in both excitable and nonexcitable cells. Available
data on transient receptor potential conical (TRPC) proteinExperimental Diabetes Research 5
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Figure 2: Relative gene expression Mean (±SEM) data of ER stress markers namely, PERK (a), GRP78 (b), IRE1α (c), XBP-1 (d), ATF6 (e),
CHOP (f). ∗P<0.05 compared to control, #P<0.05 compared to GLT, ∗∗P<0.05 compared to tunicamycin.
indicate that these proteins initiate Ca2+ entry pathways and
areessentialinmaintaining cytosolic,ER,andmitochondrial
Ca2+ levels [26]. Alterations in Ca2+ homeostasis have been
suggested in diabetes and associated complications [27, 28].
Zhuetal.[28]haverecentlyreviewedaroleforTRPchannels
and their implications in metabolic diseases. Activity of
TRPC is physiologically important as Ca2+ concentrations
withintheERmustbemaintainedatsuﬃcientlevelsinorder
for the organelle to carry out many of its fundamental func-
tions including protein folding and traﬃcking. However, loss
of Ca2+ homeostasis due to improper TRPC activation could
lead to ER stress responses, and even apoptosis [29]. While6 Experimental Diabetes Research
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Figure 3: (A) Representative protein expression data on ER stress protein markers, namely, PERK (1), GRP78 (2), IRE1α (3), and CHOP
(4). (B) Cumulative histogram data Mean (±SEM) of ER stress markers, namely, PERK (a), GRP78 (b), IRE1α (c) and CHOP (d). ∗P<0.05
compared to control, #P<0.05 compared to GLT, ∗∗P<0.05 compared to tunicamycin.
oxidative stress could result in cellular defects including a
defect in ER Ca2+ uptake and Ca2+ eﬄux, thereby increasing
[Ca2+]i and Ca2+ inﬂux [30], several TRPC families have also
been shown directly activated in response to oxidative stress
[31]. In our study, both glucolipotoxicity and tunicamycin
resulted in increased ROS generation in monocytes and, at
the transcription level, we have also witnessed the increased
TRPC6 mRNA expression. Among the TRPC subfamily
of TRP channels, TRPC6 is gated by signal transduction
pathways that activate C-type phospholipases as well as
by direct exposure to diacylglycerols [32]. Recent studies
emphasize a pathophysiological role of TRPC6 in several
disease states [33, 34] and it appears to be an emerging drug
target. Altered TRPC6 regulation and impaired capacitative
calcium entry have been shown in vessels of diabetic patients
[35]. While a role for oxidative stress has been implicated
in the pathogenesis of Type 2 diabetes and its micro- and
macrovascular complications [20], TRPC6 mRNA was alsoExperimental Diabetes Research 7
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Figure 5: (a) Mean (±SEM) percentage DNA damage under diﬀerent experimental conditions. ∗P<0.05 compared to control, #P<0.05
compared to GLT, ∗∗P<0.05 compared to tunicamycin. (b) Mean (±SEM) Caspase 3 activity under diﬀerent experimental conditions.
∗P<0.05 compared to control, #P<0.05 compared to GLT, ∗∗P<0.05 compared to tunicamycin.
shown signiﬁcantly higher in monocytes from patients with
type2diabetes[36]pointingtoanovelpathwayforincreased
activationofmonocytesandhenceatherosclerosisinpatients
with diabetes.
ER stress is one of the damaging stresses resulting from
glucolipotoxicity which can lead to apoptosis when the stress
is prolonged or uncontrolled. Komura et al. [37] have shown
that monocytes of diabetic patients are not as eﬃcient in
phagocytosing as in normal healthy people and electron
microscopic examination of monocytes revealed morpho-
logic alterations in the ER of cells derived from patients
with diabetes. Although it has been known that activation
of the CHOP pathway of the UPR can cause apoptosis, the
molecular mechanisms linking CHOP to death execution
pathways is poorly understood. Our results here show that
apoptosis might be executed by the increased activation
of caspase-3 under glucolipotoxicity. Since autophagy has
been proposed to operate as an alternative cell death
mechanism or act upstream of apoptosis [38], it is plausible
that glucolipotoxicity-induced ER stress could also promote
cell death via autophagy [39, 40]. ER stress-induced UPR
activationcanalsoinﬂuencetheexpressionofcertaininﬂam-
matory cytokines [41] rendering the monocyte intrinsically
proinﬂammatory which might have drastic consequences
when monocytes inﬁltrate the intima of the vessel wall.
Recent work has provided evidence for a calcium dependent
mechanisminERstress-inducedmacrophageapoptosis[42].
The increased mRNA levels of TRPC-6 seen in our study also
support this. Since caspase and the downstream apoptosis
eﬀectormoleculesareCa2+-dependent,futurestudiesshould
also focus on the involvement of intracellular calcium in the
induction of apoptosis in ER-stressed cellsunder glucose and
lipid dyshomeostasis.
In our study, glucolipotoxicity-induced ROS generation
and increased ER stress markers seen under glucolipotoxicity
were normalized by PBA. Drugs that interfere with ER
stress have wide therapeutic potential and recently chemical
chaperones like tauroursodeoxycholic acid (TUDCA), and
PBA received much attention because of their ER stress
alleviating activities as these compounds improve ER folding
capacity and help in stabilizing protein conformation [43].
PBA was found to be protective in in vitro and in vivo models
of diabetes [43–45]. Accumulating evidence suggests that
protein folding and generation of reactive oxygen species
(ROS) as a byproduct of protein oxidation in the ER are
closely linked events. While facilitating appropriate protein
folding, PBA helps maintaining the balance between ER
oxidoreductin 1 (ERO1) and protein disulﬁde isomerase
(PDI) and thereby reduces the ROS levels generated during
protein oxidation [46]. It has also been shown that PBA
counteracts oxidative stress by upregulating the expression
and activity of superoxide dismutase (SOD) [47, 48]. Luo8 Experimental Diabetes Research
etal.[49]have alsodemonstratedPBA inhibition ofNADPH
oxidase activity and emphasized a dual regulation ER stress
and oxidative stress by PBA. Erbay et al. [50] demonstrated
thatmitigationofERstresswithPBAprotectedmacrophages
against lipotoxic death and atherosclerosis by suppression of
XBP1splicingandCHOPexpression.PBAhasbeenshownto
regulate ER stress and oﬀer potential therapeutic beneﬁts in
several preclinical models of human diseases including type
2 diabetes [43, 51–55]. As an orally bioavailable terminal
aromatic substituted fatty acid, PBA has been used for the
treatment of urea cycle disorders [56]. More importantly,
oral treatment of PBA was recently shown preventing lipid-
inducedimpairmentininsulinsensitivityandb-cellfunction
in humans [57].
To conclude, our study exposes the convergence of ER
stress, oxidative stress and apoptosis in the presence of glu-
colipotoxicityinmonocytesandpointsoutERstressnetwork
as a novel drug-targetable pathway. Our results also empha-
size that chemical chaperones enhance the adaptive capacity
of the ER, and on further evaluation in appropriate clinical
trials, could serve as potent antidiabetic/antiatherosclerotic
modalitieswithpotentialapplicationinthetreatmentoftype
2 diabetes and its vascular complications like atherosclerosis.
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XBP-1: X box binding Protein
ATF-6: Activating transcription factor-6
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